GSK plc
GLAXF
$26.08
-$0.80-2.98%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -0.55% | 8.03% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -0.55% | 8.03% | |||
| Cost of Revenue | 15.28% | 4.39% | |||
| Gross Profit | -6.17% | 9.39% | |||
| SG&A Expenses | 21.63% | 2.41% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 16.23% | -109.68% | |||
| Total Operating Expenses | 26.10% | -1.39% | |||
| Operating Income | -47.80% | 30.06% | |||
| Income Before Tax | -61.85% | 31.38% | |||
| Income Tax Expenses | -29.50% | 30.68% | |||
| Earnings from Continuing Operations | -66.56% | 31.48% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 31.48% | 34.86% | |||
| Net Income | -68.84% | 40.81% | |||
| EBIT | -47.80% | 30.06% | |||
| EBITDA | -30.57% | 8.59% | |||
| EPS Basic | -68.72% | 41.84% | |||
| Normalized Basic EPS | -51.67% | 44.03% | |||
| EPS Diluted | -68.75% | 41.20% | |||
| Normalized Diluted EPS | -51.65% | 43.26% | |||
| Average Basic Shares Outstanding | -0.37% | -0.71% | |||
| Average Diluted Shares Outstanding | -0.39% | -0.19% | |||
| Dividend Per Share | 10.99% | 0.94% | |||
| Payout Ratio | 2.15% | -0.29% | |||